WindMIL Therapeutics
PrivateLast Round
Series B
Jun 18, 2018
Total Funding Raised
$43.5M
Company Overview
WindMIL Therapeutics operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Series B round in June 2018.
WindMIL Therapeutics is a biotechnology company that develops autologous cell therapies based on marrow-infiltrating lymphocytes (MILs) for cancer immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WindMIL Therapeutics Comparables
Compare WindMIL Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Triumvira Immunologics | 81% | |
| Marker Therapeutics Inc | 77% | |
| Rapa Therapeutics | 76% |
For institutional investors. Book with your work email.
WindMIL Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 18, 2018 | ||||
| Series A | Mar 24, 2016 |
For institutional investors. Book with your work email.
WindMIL Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foxkiser | Series B, Series A |
| Domain Associates | Series B, Series A |
| Kintegral Asset Management | Series B |
| Qiming | Series B |
| Forward Equity Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2018
$33M round led by Qiming
- Mar 24, 2016
$11M round led by Domain Associates.
For institutional investors. Book with your work email.
WindMIL Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about WindMIL Therapeutics's valuation, stock price, and market status.
Is WindMIL Therapeutics a public or private company?
WindMIL Therapeutics is a private company.
What is the current stock price of WindMIL Therapeutics?
WindMIL Therapeutics is a private company, so its shares have no public market price. Caplight tracks WindMIL Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is WindMIL Therapeutics worth (valuation)?
Valuation information for WindMIL Therapeutics is not publicly available.
Can I buy WindMIL Therapeutics stock?
WindMIL Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was WindMIL Therapeutics's last funding round?
WindMIL Therapeutics's most recent funding round was Series B on June 18, 2018.
Who are the main investors in WindMIL Therapeutics?
Key investors in WindMIL Therapeutics include Domain Associates, Qiming.
Will WindMIL Therapeutics IPO soon?
No public IPO plans have been announced for WindMIL Therapeutics.
How can I track WindMIL Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in WindMIL Therapeutics's shares on secondary markets.